{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:48:31Z","timestamp":1782730111974,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04894-3","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:26:18Z","timestamp":1778063178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The value of the serum cytokine-to-immune ratio model in predicting the progression-free survival after interventional therapy for hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Jun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"4894_CR1","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"25","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, et al. Impact of middle hepatic vein resection during hemihepatectomy on surgical outcomes and long-term prognosis in hepatocellular carcinoma: a retrospective study. J Hepatocellular Carcinoma. 2025;25:2681\u201392. https:\/\/doi.org\/10.2147\/JHC.S556306.","journal-title":"J Hepatocellular Carcinoma"},{"issue":"1","key":"4894_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","volume":"23","author":"YT Chan","year":"2024","unstructured":"Chan YT, Zhang C, Wu J, et al. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Mol Cancer. 2024;23(1):189. https:\/\/doi.org\/10.1186\/s12943-024-02101-z.","journal-title":"Mol Cancer"},{"key":"4894_CR3","doi-asserted-by":"publisher","first-page":"123952DOI","DOI":"10.1016\/j.biomaterials.2025.123952","volume":"329","author":"B Chen","year":"2026","unstructured":"Chen B, Xing H, Liu X, et al. Spatiotemporal controlled disintegration enabling injected magnetic hydrogel for percutaneous hepatocellular carcinoma treatment. Biomaterials. 2026;329:123952DOI. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123952.","journal-title":"Biomaterials"},{"key":"4894_CR4","doi-asserted-by":"publisher","first-page":"106564DOI","DOI":"10.1016\/j.phrs.2022.106564","volume":"187","author":"Z Chen","year":"2023","unstructured":"Chen Z, Li H, Li Z, et al. SHH\/GLI2-TGF-\u03b21 feedback loop between cancer cells and tumor-associated macrophages maintains epithelial-mesenchymal transition and endoplasmic reticulum homeostasis in cholangiocarcinoma. Pharmacol Res. 2023;187:106564DOI. https:\/\/doi.org\/10.1016\/j.phrs.2022.106564.","journal-title":"Pharmacol Res"},{"key":"4894_CR5","doi-asserted-by":"publisher","unstructured":"Cui J, Che Z, Zou L, et al. JP1 normalizes tumor vasculature to suppress metastasis and facilitate drug delivery by inhibiting IL-8. JCI Insight. 2023;8(12). https:\/\/doi.org\/10.1172\/jci.insight.161675.","DOI":"10.1172\/jci.insight.161675"},{"key":"4894_CR6","doi-asserted-by":"publisher","unstructured":"Li J, Liang YB, Wang QB, et al. Rechallenge with Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Narrative Review. Liver Cancer Published online Oct. 2025;31. https:\/\/doi.org\/10.1159\/000549355.","DOI":"10.1159\/000549355"},{"key":"4894_CR7","doi-asserted-by":"publisher","first-page":"1519999","DOI":"10.3389\/fimmu.2024.1519999","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Liang YB, Wang QB, et al. Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysis. Front Immunol. 2025;15:1519999. https:\/\/doi.org\/10.3389\/fimmu.2024.1519999.","journal-title":"Front Immunol"},{"key":"4894_CR8","doi-asserted-by":"publisher","unstructured":"Gu S, Jiang M, Zhang B. Microcystin-LR in Primary Liver Cancers: An Overview. Toxins (Basel). 2022;14(10). https:\/\/doi.org\/10.3390\/toxins14100715.","DOI":"10.3390\/toxins14100715"},{"key":"4894_CR9","doi-asserted-by":"publisher","unstructured":"Habanjar O, Bingula R, Decombat C, et al. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment. Int J Mol Sci. 2023;24(4). https:\/\/doi.org\/10.3390\/ijms24044002.","DOI":"10.3390\/ijms24044002"},{"key":"4894_CR10","doi-asserted-by":"publisher","first-page":"108223DOI","DOI":"10.1016\/j.compbiomed.2024.108223","volume":"171","author":"S Hao","year":"2024","unstructured":"Hao S, Shen L, Liu P, et al. Development of a prognostic model for muscle-invasive bladder cancer using glutamine metabolism. Comput Biol Med. 2024;171:108223DOI. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108223.","journal-title":"Comput Biol Med"},{"issue":"1","key":"4894_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3760\/cma.j.cn501113-20210910-00466","volume":"30","author":"YQ Hu","year":"2022","unstructured":"Hu YQ, Wang N, Ran XP, et al. [Real-world study evaluating the incidence of liver damage conditions in patients with primary liver cancer using immune checkpoint inhibitor-based combination therapy]. Zhonghua Gan Zang Bing Za Zhi. 2022;30(1):57\u201362. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20210910-00466.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"4894_CR12","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.ymthe.2025.02.002","volume":"33","author":"TT Kwong","year":"2025","unstructured":"Kwong TT, Xiong Z, Zhang Y, et al. Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8\/CXCR2 signaling. Mol Ther. 2025;33(4):1659\u201373. https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.002.","journal-title":"Mol Ther"},{"issue":"10","key":"4894_CR13","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1016\/s1470-2045(22)00372-2","volume":"23","author":"CL Lorentzen","year":"2022","unstructured":"Lorentzen CL, Haanen JB, Met \u00d6, et al. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment. Lancet Oncol. 2022;23(10):e450\u20138. https:\/\/doi.org\/10.1016\/s1470-2045(22)00372-2.","journal-title":"Lancet Oncol"},{"key":"4894_CR14","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"QB Wang","year":"2025","unstructured":"Wang QB, Luo WL, Li YK, et al. Tumor compression of the hepatic or portal vein predicts the presence of microvascular invasion and satellite nodules in hepatocellular carcinoma: a retrospective study. J Hepatocellular Carcinoma. 2025;12:2055\u201367. https:\/\/doi.org\/10.2147\/JHC.S544589.","journal-title":"J Hepatocellular Carcinoma"},{"issue":"8","key":"4894_CR15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3760\/cma.j.cn501225-20220327-00094","volume":"38","author":"JQ Lou","year":"2022","unstructured":"Lou JQ, Li Q, Cui QW, et al. [A prospective randomized controlled study on the curative effects of enteral immunonutrition support therapy in adult burn patients at nutritional risk]. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022;38(8):722\u201334. https:\/\/doi.org\/10.3760\/cma.j.cn501225-20220327-00094.","journal-title":"Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi"},{"issue":"3","key":"4894_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/hep.0000000000001195","volume":"82","author":"Y Luo","year":"2025","unstructured":"Luo Y, Fraser L, Jezykowski J, et al. Interleukin 8-CXCR2-mediated neutrophil extracellular trap formation in biliary atresia associated with neutrophil extracellular trap-induced stellate cell activation. Hepatology. 2025;82(3):552\u201365. https:\/\/doi.org\/10.1097\/hep.0000000000001195.","journal-title":"Hepatology"},{"issue":"1","key":"4894_CR17","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1038\/s41598-024-53565-4","volume":"14","author":"Z Ma","year":"2024","unstructured":"Ma Z, Chen M, Liu X, et al. Identification and verification of a prognostic autophagy-related gene signature in hepatocellular carcinoma. Sci Rep. 2024;14(1):3032. https:\/\/doi.org\/10.1038\/s41598-024-53565-4.","journal-title":"Sci Rep"},{"issue":"6","key":"4894_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021.","journal-title":"J Hepatol"},{"key":"4894_CR19","doi-asserted-by":"publisher","first-page":"790995","DOI":"10.3389\/fmed.2022.790995","volume":"9","author":"S Schlichtner","year":"2022","unstructured":"Schlichtner S, Yasinska IM, Ruggiero S, et al. Expression of the Immune Checkpoint Protein VISTA Is Differentially Regulated by the TGF-\u03b21 - Smad3 Signaling Pathway in Rapidly Proliferating Human Cells and T Lymphocytes. Front Med (Lausanne). 2022;9:790995. https:\/\/doi.org\/10.3389\/fmed.2022.790995.","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"4894_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864\u201384. https:\/\/doi.org\/10.1038\/s41571-023-00825-3.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4894_CR21","doi-asserted-by":"publisher","first-page":"2607229","DOI":"10.1080\/07853890.2025.2607229","volume":"58","author":"R Song","year":"2026","unstructured":"Song R, Li M, Tang S, et al. Immunotherapy for virus-related hepatocellular carcinoma: recent progress and future directions. Ann Med. 2026;58(1):2607229. https:\/\/doi.org\/10.1080\/07853890.2025.2607229.","journal-title":"Ann Med"},{"issue":"4","key":"4894_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/fcp.12990","volume":"38","author":"YM Tamim","year":"2024","unstructured":"Tamim YM, Nagy AA, Abdellah AM, et al. Anticancer effect of propranolol on diethylnitrosamine-induced hepatocellular carcinoma rat model. Fundam Clin Pharmacol. 2024;38(4):742\u201357. https:\/\/doi.org\/10.1111\/fcp.12990.","journal-title":"Fundam Clin Pharmacol"},{"key":"4894_CR23","doi-asserted-by":"publisher","first-page":"147752DOI","DOI":"10.1016\/j.brainres.2021.147752","volume":"1776","author":"UV Wesley","year":"2022","unstructured":"Wesley UV, Sutton I, Clark PA, et al. Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis. Brain Res. 2022;1776:147752DOI. https:\/\/doi.org\/10.1016\/j.brainres.2021.147752.","journal-title":"Brain Res"},{"key":"4894_CR24","doi-asserted-by":"publisher","unstructured":"Xia Y, Tang W, Qian X, et al. Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial. J Immunother Cancer. 2022;10(4). https:\/\/doi.org\/10.1136\/jitc-2022-004656.","DOI":"10.1136\/jitc-2022-004656"},{"issue":"1","key":"4894_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","volume":"80","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xu J, Zhou S, et al. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. J Hepatol. 2024;80(1):82\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.006.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04894-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04894-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:32:44Z","timestamp":1782729164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04894-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4894"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04894-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Qilu Hospital (Qingdao), Cheeloo College Medicine, Shandong University (No. 2024 QL-0312).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participants agreed for the publication of identifying images or other personal or clinical details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}